Bioprinting the Cancer Microenvironment

Yu Shrike Zhang, Margaux Duchamp, Rahmi Oklu, Leif W. Ellisen, Robert Langer, Ali Khademhosseini

Research output: Contribution to journalReview article

74 Citations (Scopus)

Abstract

Cancer is intrinsically complex, comprising both heterogeneous cellular compositions and microenvironmental cues. During the various stages of cancer initiation, development, and metastasis, cell-cell interactions (involving vascular and immune cells besides cancerous cells) as well as cell-extracellular matrix (ECM) interactions (e.g., alteration in stiffness and composition of the surrounding matrix) play major roles. Conventional cancer models both two- and three-dimensional (2D and 3D) present numerous limitations as they lack good vascularization and cannot mimic the complexity of tumors, thereby restricting their use as biomimetic models for applications such as drug screening and fundamental cancer biology studies. Bioprinting as an emerging biofabrication platform enables the creation of high-resolution 3D structures and has been extensively used in the past decade to model multiple organs and diseases. More recently, this versatile technique has further found its application in studying cancer genesis, growth, metastasis, and drug responses through creation of accurate models that recreate the complexity of the cancer microenvironment. In this review we will focus first on cancer biology and limitations with current cancer models. We then detail the current bioprinting strategies including the selection of bioinks for capturing the properties of the tumor matrices, after which we discuss bioprinting of vascular structures that are critical toward construction of complex 3D cancer organoids. We finally conclude with current literature on bioprinted cancer models and propose future perspectives.

Original languageEnglish (US)
Pages (from-to)1710-1721
Number of pages12
JournalACS Biomaterial Science and Engineering
Volume2
Issue number10
DOIs
StatePublished - Oct 10 2016

Fingerprint

Tumors
Biomimetics
Chemical analysis
Pharmaceutical Preparations
Screening
Stiffness

Keywords

  • bioprinting
  • cancer biology
  • cancer model
  • drug screening
  • vascularization

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering

Cite this

Zhang, Y. S., Duchamp, M., Oklu, R., Ellisen, L. W., Langer, R., & Khademhosseini, A. (2016). Bioprinting the Cancer Microenvironment. ACS Biomaterial Science and Engineering, 2(10), 1710-1721. https://doi.org/10.1021/acsbiomaterials.6b00246

Bioprinting the Cancer Microenvironment. / Zhang, Yu Shrike; Duchamp, Margaux; Oklu, Rahmi; Ellisen, Leif W.; Langer, Robert; Khademhosseini, Ali.

In: ACS Biomaterial Science and Engineering, Vol. 2, No. 10, 10.10.2016, p. 1710-1721.

Research output: Contribution to journalReview article

Zhang, YS, Duchamp, M, Oklu, R, Ellisen, LW, Langer, R & Khademhosseini, A 2016, 'Bioprinting the Cancer Microenvironment', ACS Biomaterial Science and Engineering, vol. 2, no. 10, pp. 1710-1721. https://doi.org/10.1021/acsbiomaterials.6b00246
Zhang YS, Duchamp M, Oklu R, Ellisen LW, Langer R, Khademhosseini A. Bioprinting the Cancer Microenvironment. ACS Biomaterial Science and Engineering. 2016 Oct 10;2(10):1710-1721. https://doi.org/10.1021/acsbiomaterials.6b00246
Zhang, Yu Shrike ; Duchamp, Margaux ; Oklu, Rahmi ; Ellisen, Leif W. ; Langer, Robert ; Khademhosseini, Ali. / Bioprinting the Cancer Microenvironment. In: ACS Biomaterial Science and Engineering. 2016 ; Vol. 2, No. 10. pp. 1710-1721.
@article{bf6b73922d0b4b808bdd32cc256c7dfd,
title = "Bioprinting the Cancer Microenvironment",
abstract = "Cancer is intrinsically complex, comprising both heterogeneous cellular compositions and microenvironmental cues. During the various stages of cancer initiation, development, and metastasis, cell-cell interactions (involving vascular and immune cells besides cancerous cells) as well as cell-extracellular matrix (ECM) interactions (e.g., alteration in stiffness and composition of the surrounding matrix) play major roles. Conventional cancer models both two- and three-dimensional (2D and 3D) present numerous limitations as they lack good vascularization and cannot mimic the complexity of tumors, thereby restricting their use as biomimetic models for applications such as drug screening and fundamental cancer biology studies. Bioprinting as an emerging biofabrication platform enables the creation of high-resolution 3D structures and has been extensively used in the past decade to model multiple organs and diseases. More recently, this versatile technique has further found its application in studying cancer genesis, growth, metastasis, and drug responses through creation of accurate models that recreate the complexity of the cancer microenvironment. In this review we will focus first on cancer biology and limitations with current cancer models. We then detail the current bioprinting strategies including the selection of bioinks for capturing the properties of the tumor matrices, after which we discuss bioprinting of vascular structures that are critical toward construction of complex 3D cancer organoids. We finally conclude with current literature on bioprinted cancer models and propose future perspectives.",
keywords = "bioprinting, cancer biology, cancer model, drug screening, vascularization",
author = "Zhang, {Yu Shrike} and Margaux Duchamp and Rahmi Oklu and Ellisen, {Leif W.} and Robert Langer and Ali Khademhosseini",
year = "2016",
month = "10",
day = "10",
doi = "10.1021/acsbiomaterials.6b00246",
language = "English (US)",
volume = "2",
pages = "1710--1721",
journal = "ACS Biomaterials Science and Engineering",
issn = "2373-9878",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Bioprinting the Cancer Microenvironment

AU - Zhang, Yu Shrike

AU - Duchamp, Margaux

AU - Oklu, Rahmi

AU - Ellisen, Leif W.

AU - Langer, Robert

AU - Khademhosseini, Ali

PY - 2016/10/10

Y1 - 2016/10/10

N2 - Cancer is intrinsically complex, comprising both heterogeneous cellular compositions and microenvironmental cues. During the various stages of cancer initiation, development, and metastasis, cell-cell interactions (involving vascular and immune cells besides cancerous cells) as well as cell-extracellular matrix (ECM) interactions (e.g., alteration in stiffness and composition of the surrounding matrix) play major roles. Conventional cancer models both two- and three-dimensional (2D and 3D) present numerous limitations as they lack good vascularization and cannot mimic the complexity of tumors, thereby restricting their use as biomimetic models for applications such as drug screening and fundamental cancer biology studies. Bioprinting as an emerging biofabrication platform enables the creation of high-resolution 3D structures and has been extensively used in the past decade to model multiple organs and diseases. More recently, this versatile technique has further found its application in studying cancer genesis, growth, metastasis, and drug responses through creation of accurate models that recreate the complexity of the cancer microenvironment. In this review we will focus first on cancer biology and limitations with current cancer models. We then detail the current bioprinting strategies including the selection of bioinks for capturing the properties of the tumor matrices, after which we discuss bioprinting of vascular structures that are critical toward construction of complex 3D cancer organoids. We finally conclude with current literature on bioprinted cancer models and propose future perspectives.

AB - Cancer is intrinsically complex, comprising both heterogeneous cellular compositions and microenvironmental cues. During the various stages of cancer initiation, development, and metastasis, cell-cell interactions (involving vascular and immune cells besides cancerous cells) as well as cell-extracellular matrix (ECM) interactions (e.g., alteration in stiffness and composition of the surrounding matrix) play major roles. Conventional cancer models both two- and three-dimensional (2D and 3D) present numerous limitations as they lack good vascularization and cannot mimic the complexity of tumors, thereby restricting their use as biomimetic models for applications such as drug screening and fundamental cancer biology studies. Bioprinting as an emerging biofabrication platform enables the creation of high-resolution 3D structures and has been extensively used in the past decade to model multiple organs and diseases. More recently, this versatile technique has further found its application in studying cancer genesis, growth, metastasis, and drug responses through creation of accurate models that recreate the complexity of the cancer microenvironment. In this review we will focus first on cancer biology and limitations with current cancer models. We then detail the current bioprinting strategies including the selection of bioinks for capturing the properties of the tumor matrices, after which we discuss bioprinting of vascular structures that are critical toward construction of complex 3D cancer organoids. We finally conclude with current literature on bioprinted cancer models and propose future perspectives.

KW - bioprinting

KW - cancer biology

KW - cancer model

KW - drug screening

KW - vascularization

UR - http://www.scopus.com/inward/record.url?scp=84991000712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991000712&partnerID=8YFLogxK

U2 - 10.1021/acsbiomaterials.6b00246

DO - 10.1021/acsbiomaterials.6b00246

M3 - Review article

AN - SCOPUS:84991000712

VL - 2

SP - 1710

EP - 1721

JO - ACS Biomaterials Science and Engineering

JF - ACS Biomaterials Science and Engineering

SN - 2373-9878

IS - 10

ER -